-
5-year Longitudinal Changes in Non-motor Symptoms and Their Association With Motor Progression in Parkinson’s Disease
-
7 Tesla MRI with Quantitative Susceptibility Mapping: Quantitative focal measurements and qualitative grading of the substantia nigra as a biomarker for Parkinson’s Disease
-
A 6-month Pilot Study of Disease-Modifying Potential of Long-term Transcutaneous Auricular Vagus Nerve Stimulation in Parkinson’s Disease
-
A biomarker of Huntington’s disease progression derived from deep neural speech representations
-
A Brief Clinical Test Battery Predicting UPDRS II Disability in Parkinson Disease
-
A Case of Anti-NMDA Receptor Encephalitis Presenting with Refractory Myoclonus and Perioral Dyskinesia during the First Trimester of Pregnancy
-
A case of difficulty extubating after General Anesthesia Deep Brain Stimulation (DBS) surgery
-
A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson’s disease symptoms
-
A Case of NUS1 Spectrum Disorder with Adult-Onset Psychosis
-
A Case of Progressive Cerebellar Syndrome with Ataxia as a First Sign
2026 International Congress
October 4-8, 2026. Seoul, Korea.